Daiwa Securities Group Inc. - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 2 filers reported holding ARRAY BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$64,000
+88.2%
1,3880.0%0.00%
Q1 2019$34,000
+112.5%
1,388
+27.5%
0.00%
Q4 2018$16,000
-5.9%
1,0890.0%0.00%
Q3 2018$17,000
-5.6%
1,0890.0%0.00%
Q2 2018$18,0000.0%1,0890.0%0.00%
Q1 2018$18,0001,0890.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q3 2019
NameSharesValueWeighting ↓
Advisory Services Network, LLC 3,442$159,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ARRAY BIOPHARMA INC shareholders